N. Willcutt

A phase I trial of romidepsin in combination with gemcitabine in patients with pancreatic and other advanced solid tumors

Suzanne F. Jones, H. Burris, J. Infante, 2008 .

Gemcitabine in the Second-Line Therapy of Patients with Carcinoma of Unknown Primary Site: A Phase II Trial of the Minnie Pearl Cancer Research Network

J. Hainsworth, H. Burris, J. Bramham, 2001, Cancer investigation.

A phase I trial of weekly paclitaxel plus prolonged oral eniluracil/5-fluorouracil in patients with refractory malignancies.

Suzanne F. Jones, J. Hainsworth, H. Burris, 2002, The oncologist.

Phase I. Trial of irinotecan plus carboplatin in two dose schedules.

Suzanne F. Jones, J. Hainsworth, H. Burris, 2003, Oncology.

A phase I study of the dual kinase inhibitor GW572016 in combination with paclitaxel (EGF10009).

J. Hainsworth, H. Burris, N. Peacock, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I. Trial of irinotecan and temozolomide in patients with solid tumors.

Suzanne F. Jones, J. Hainsworth, H. Burris, 2003, Oncology.

A phase I trial of protracted oral fixed‐dose temozolomide

Suzanne F. Jones, J. Hainsworth, F. Greco, 2005, Cancer.